Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sosondowah ankyrin repeat domain family member A (SOWAHA/ANKRD43) is a protein-coding gene that encodes a member of the ankyrin repeat domain protein family, characterized by the presence of ankyrin repeats—a common structural motif that facilitates protein-protein interactions[6]. The gene is expressed in various human tissues, but its precise biological function and clinical relevance remain poorly defined. Rare associations with testicular Leydig cell tumors and sex cord-stromal neoplasms have been reported, but SOWAHA is not considered a validated therapeutic target, biomarker, or a molecule of high clinical importance at present[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sosondowah ankyrin repeat domain family member A (SOWAHA).